HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Toloza, E. M. Articles by McCrory, D. C. Search for Related Content PubMed PubMed Citation Articles by Toloza, E. M. Articles by McCrory, D. C.

Noninvasive Staging of Non-small Cell Lung Cancer^*

A Review of the Current Evidence

^* From the Departments of Surgery (Dr. Toloza) and Medicine (Drs. Harpole and McCrory), Duke University Medical Center, Durham, NC.

Correspondence to: Eric M. Toloza, MD, PhD, Duke Thoracic Oncology, DUMC Box 3048, Durham, NC 27710; e-mail: toloz001{at}mc.duke.edu

Study objectives: To determine the test performance characteristics of CT scanning, positron emission tomography (PET) scanning, MRI, and endoscopic ultrasound (EUS) for staging the mediastinum, and to evaluate the accuracy of the clinical evaluation (ie, symptoms, physical findings, or routine blood test results) for predicting metastatic disease in patients in whom non-small cell lung cancer or small cell lung cancer is diagnosed.

Design, setting, and participants: Systematic searches of MEDLINE, HealthStar, and Cochrane Library databases to July 2001, and of print bibliographies. Studies evaluating the staging results of CT scanning, PET scanning, MRI, or EUS, with either tissue histologic confirmation or long-term clinical follow-up, were included. The performance of the clinical evaluation was compared against the results of brain and abdominal CT scans and radionuclide bone scans.

Measurement and results: Pooled sensitivities and specificities for staging the mediastinum were as follows: for CT scanning: sensitivity, 0.57 (95% confidence interval [CI], 0.49 to 0.66); specificity, 0.82 (95% CI, 0.77 to 0.86); for PET scanning: sensitivity, 0.84 (95% CI, 0.78 to 0.89); specificity, 0.89 (95% CI, 0.83 to 0.93); and for EUS: sensitivity, 0.78 (95% CI, 0.61 to 0.89); specificity, 0.71 (95% CI, 0.56 to 0.82). For the evaluation of brain metastases, the summary estimate of the negative predictive value (NPV) of the clinical neurologic evaluation was 0.94 (95% CI, 0.91 to 0.96). For detecting adrenal and/or liver metastases, the summary NPV of the clinical evaluation was 0.95 (95% CI, 0.93 to 0.96), and for detecting bone metastases, it was 0.90 (95% CI, 0.86 to 0.93).

Conclusions: PET scanning is more accurate than CT scanning or EUS for detecting mediastinal metastases. The NPVs of the clinical evaluations for brain, abdominal, and bone metastases are 90%, suggesting that routinely imaging asymptomatic lung cancer patients may not be necessary. However, more definitive prospective studies that better define the patient population and improved reference standards are necessary to more accurately assess the true NPV of the clinical evaluation.

Key Words: CT • lung neoplasms • meta-analysis • predictive value of tests • radiograph • sensitivity • specificity

This article has been cited by other articles:

				F. J. F. Herth, R. Eberhardt, M. Krasnik, and A. Ernst Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration of Lymph Nodes in the Radiologically and Positron Emission Tomography-Normal Mediastinum in Patients With Lung Cancer Chest, April 1, 2008; 133(4): 887 - 891. [Abstract] [Full Text] [PDF]

				M. S. Sawhney, Y. Bakman, A. M. Holmstrom, D. B. Nelson, F. A. Lederle, and R. F. Kelly Impact of Preoperative Endoscopic Ultrasound on Non-small Cell Lung Cancer Staging Chest, September 1, 2007; 132(3): 916 - 921. [Abstract] [Full Text] [PDF]

				B.-T. Kim, K. S. Lee, S. S. Shim, J. Y. Choi, O J. Kwon, H. Kim, Y. M. Shim, J. Kim, and S. Kim Stage T1 Non-Small Cell Lung Cancer: Preoperative Mediastinal Nodal Staging with Integrated FDG PET/CT--A Prospective Study Radiology, September 11, 2006; (2006) 2412051173. [Abstract] [Full Text]

				D. Lardinois New Horizons in Staging for Non-Small-Cell Lung Cancer J. Clin. Oncol., April 20, 2006; 24(12): 1785 - 1787. [Full Text] [PDF]

				A. J. de Langen, P. Raijmakers, I. Riphagen, M. A. Paul, and O. S. Hoekstra The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis Eur. J. Cardiothorac. Surg., January 1, 2006; 29(1): 26 - 29. [Abstract] [Full Text] [PDF]

				R. J. Cerfolio, A. S. Bryant, B. Ojha, and M. Eloubeidi Improving the Inaccuracies of Clinical Staging of Patients with NSCLC: A Prospective Trial Ann. Thorac. Surg., October 1, 2005; 80(4): 1207 - 1214. [Abstract] [Full Text] [PDF]

				M. A. Eloubeidi, A. Tamhane, V. K. Chen, and R. J. Cerfolio Endoscopic Ultrasound-Guided Fine-Needle Aspiration in Patients With Non-Small Cell Lung Cancer and Prior Negative Mediastinoscopy Ann. Thorac. Surg., October 1, 2005; 80(4): 1231 - 1239. [Abstract] [Full Text] [PDF]

				J. T. Annema, M. I. Versteegh, M. Veselic, L. Welker, T. Mauad, J. K. Sont, L. N. A. Willems, and K. F. Rabe Endoscopic Ultrasound Added to Mediastinoscopy for Preoperative Staging of Patients With Lung Cancer JAMA, August 24, 2005; 294(8): 931 - 936. [Abstract] [Full Text] [PDF]

				P. D. Leyn and T. Lerut Conventional mediastinoscopy MMCTS, March 24, 2005; 2005(0324): 158. [Abstract] [Full Text] [PDF]

				J. Kuzdzal, M. Zielinski, B. Papla, A. Szlubowski, L. Hauer, T. Nabialek, W. Sosnicki, and J. Pankowski Transcervical extended mediastinal lymphadenectomy--the new operative technique and early results in lung cancer staging Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 384 - 390. [Abstract] [Full Text] [PDF]

				M. A. Eloubeidi, R. J. Cerfolio, V. K. Chen, R. Desmond, S. Syed, and B. Ojha Endoscopic Ultrasound-Guided Fine Needle Aspiration of Mediastinal Lymph Node in Patients With Suspected Lung Cancer After Positron Emission Tomography and Computed Tomography Scans Ann. Thorac. Surg., January 1, 2005; 79(1): 263 - 268. [Abstract] [Full Text] [PDF]

				A. T. Rocha, M. McCormack, G. Montana, and G. Schreiber Association Between Lower Lobe Location and Upstaging for Early-Stage Non-small Cell Lung Cancer Chest, April 1, 2004; 125(4): 1424 - 1430. [Abstract] [Full Text] [PDF]

				G. Antoch, F. M. Vogt, L. S. Freudenberg, F. Nazaradeh, S. C. Goehde, J. Barkhausen, G. Dahmen, A. Bockisch, J. F. Debatin, and S. G. Ruehm Whole-Body Dual-Modality PET/CT and Whole-Body MRI for Tumor Staging in Oncology JAMA, December 24, 2003; 290(24): 3199 - 3206. [Abstract] [Full Text] [PDF]

				C. E. Reed, D. H. Harpole, K. E. Posther, S. L. Woolson, R. J. Downey, B. F. Meyers, R. T. Heelan, H. A. MacApinlac, S.-H. Jung, G. A. Silvestri, et al. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1943 - 1951. [Abstract] [Full Text] [PDF]

				G. A. Silvestri, B. Hoffman, and C. E. Reed One From Column A: Choosing Between CT, Positron Emission Tomography, Endoscopic Ultrasound With Fine-Needle Aspiration, Transbronchial Needle Aspiration, Thoracoscopy, Mediastinoscopy, and Mediastinotomy for Staging Lung Cancer Chest, February 1, 2003; 123(2): 333 - 335. [Full Text] [PDF]